SL Spector, LJ Smith and M Glass
Northwestern University Medical School, Chicago, Illinois.

The efficacy of 6 wk of therapy with oral ICI 204,219, a selective leukotriene D4 (LTD4) receptor antagonist, was evaluated in subjects with moderate asthma during a multicenter, double-blind, randomized, placebo-controlled, dose-ranging study. Subjects who entered the trial had been chronically treated for asthma with beta agonist alone or in combination with theophylline. Subjects were randomized to treatment with twice daily doses of ICI 204,219 (5, 10, or 20 mg) or placebo if they had an FEV1 between 40 and 75% of predicted values without bronchodilator therapy and a daytime asthma score > 10 (range 0 to 21 per wk) for 7 consecutive d. Efficacy was evaluated from the results of symptom assessments, pulmonary function tests, and rescue medication use. Of 276 subjects randomized to treatment, 266 (10 mg, n = 66; 20 mg, n = 67; 40 mg, n = 67; placebo, n = 66) were analyzed for efficacy. Diary card assessments showed that treatment with increasing doses of ICI 204,219 linearly improved five efficacy criteria without increasing the number or severity of adverse events. The 40 mg dose was more effective than placebo (p < 0.05) in reducing nighttime awakenings, first morning asthma symptoms, the daytime asthma score, and albuterol use and in increasing evening peak expiratory flow (PEF) rates as well as FEV1. Compared with baseline measurements, the 40 mg dose decreased awakenings by 46%, albuterol use by 30%, and daytime symptoms by 26% and increased FEV1 by 11%. ICI 204,219 improves objective and subjective measures of asthma severity in moderately ill asthmatic subjects and may provide a new treatment option for the disease.

This article has been cited by other articles:

				W. A. Biernacki, S. A. Kharitonov, H. M. Biernacka, and P. J. Barnes Effect of Montelukast on Exhaled Leukotrienes and Quality of Life in Asthmatic Patients Chest, October 1, 2005; 128(4): 1958 - 1963. [Abstract] [Full Text] [PDF]

				D J White, A Vanthuyne, P M Wood, and J G Ayres Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study Sex. Transm. Inf., June 1, 2004; 80(3): 219 - 222. [Abstract] [Full Text] [PDF]

				R H Green, C E Brightling, I D Pavord, and A J Wardlaw Management of asthma in adults: current therapy and future directions Postgrad. Med. J., May 1, 2003; 79(931): 259 - 267. [Abstract] [Full Text] [PDF]

				J. E. Fish, E. Israel, J. J. Murray, A. Emmett, R. Boone, S. W. Yancey, and K. A. Rickard Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy Chest, August 1, 2001; 120(2): 423 - 430. [Abstract] [Full Text] [PDF]

				L Dow, L Fowler, L Phelps, K Waters, D Coggon, A L Kinmonth, and S T Holgate Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK Thorax, June 1, 2001; 56(6): 472 - 476. [Abstract] [Full Text]

				S. S. Salvi, M. T. Krishna, A. P. Sampson, and S. T. Holgate The Anti-inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in Asthma Chest, May 1, 2001; 119(5): 1533 - 1546. [Abstract] [Full Text] [PDF]

				M. Eccles, N. Rousseau, B. Higgins, and L. Thomas Evidence-based guideline on the primary care management of asthma Fam. Pract., April 1, 2001; 18(2): 223 - 229. [Full Text] [PDF]

				O J Dempsey Leukotriene receptor antagonist therapy Postgrad. Med. J., December 1, 2000; 76(902): 767 - 773. [Abstract] [Full Text]

				A. Reicin, R. White, S. F. Weinstein, A. F. Finn Jr, H. Nguyen, I. Peszek, L. Geissler, B. C. Seidenberg, and for the Montelukast/Loratadine Study Group Montelukast, a Leukotriene Receptor Antagonist, in Combination With Loratadine, a Histamine Receptor Antagonist, in the Treatment of Chronic Asthma Arch Intern Med, September 11, 2000; 160(16): 2481 - 2488. [Abstract] [Full Text]

				J. CHRISTIAN VIRCHOW Jr., A. PRASSE, I. NAYA, L. SUMMERTON, A. HARRIS, and The Zafirlukast Study Group Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 578 - 585. [Abstract] [Full Text] [PDF]

				N. C Barnes and C. J Miller Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials Thorax, June 1, 2000; 55(6): 478 - 483. [Abstract] [Full Text]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				N. C. BARNES Effects of Antileukotrienes in the Treatment of Asthma Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S73 - 76. [Full Text] [PDF]

				S. T. HOLGATE and A. P. SAMPSON Antileukotriene Therapy . Future Directions Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S147 - 153. [Full Text] [PDF]

				Leukotriene-receptor antagonists and related compounds Can. Med. Assoc. J., November 1, 1999; 161(90111): s31 - 34. [Full Text]

				H. M. Sarau, R. S. Ames, J. Chambers, C. Ellis, N. Elshourbagy, J. J. Foley, D. B. Schmidt, R. M. Muccitelli, O. Jenkins, P. R. Murdock, et al. ACCELERATED COMMUNICATION: Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor Mol. Pharmacol., September 1, 1999; 56(3): 657 - 663. [Abstract] [Full Text]

				T. PULLERITS, L. PRAKS, B.-E. SKOOGH, R. ANI, and J. LÖTVALL Randomized Placebo-controlled Study Comparing a Leukotriene Receptor Antagonist and a Nasal Glucocorticoid in Seasonal Allergic Rhinitis Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1814 - 1818. [Abstract] [Full Text]

				K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villaran, A. Pineiro, L. X. Wei, B. C. Seidenberg, T. F. Reiss, and for the Montelukast/Beclomethasone Study Group* Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma: A Randomized, Controlled Trial Ann Intern Med, March 16, 1999; 130(6): 487 - 495. [Abstract] [Full Text] [PDF]

				J. M. Drazen, E. Israel, and P. M. O'Byrne Treatment of Asthma with Drugs Modifying the Leukotriene Pathway N. Engl. J. Med., January 21, 1999; 340(3): 197 - 206. [Full Text] [PDF]

				J. W. Georgitis The 1997 Asthma Management Guidelines and Therapeutic Issues Relating to the Treatment of Asthma Chest, January 1, 1999; 115(1): 210 - 217. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				Y. Arakida, K. Suwa, K. Ohga, M. Yokota, K. Miyata, T. Yamada, and K. Honda In Vitro Pharmacologic Profile of YM158, a New Dual Antagonist for LTD4 and TXA2 receptors J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 633 - 639. [Abstract] [Full Text]

				J. M. DRAZEN Leukotrienes as Mediators of Airway Obstruction Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S193 - S200. [Abstract] [Full Text] [PDF]

				Y. Nakamura, M. Hoshino, J. J. Sim, K. Ishii, K. Hosaka, and T. Sakamoto Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma Thorax, October 1, 1998; 53(10): 835 - 841. [Abstract] [Full Text]

				R. A. Panettieri Jr., E. M. L. Tan, V. Ciocca, M. A. Luttmann, T. B. Leonard, and D. W. P. Hay Effects of LTD4 on Human Airway Smooth Muscle Cell Proliferation, Matrix Expression, and Contraction In Vitro: Differential Sensitivity to Cysteinyl Leukotriene Receptor Antagonists Am. J. Respir. Cell Mol. Biol., September 1, 1998; 19(3): 453 - 461. [Abstract] [Full Text]

				R. J. MARTIN and S. BANKS-SCHLEGEL Chronobiology of Asthma Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 1002 - 1007. [Full Text] [PDF]

				J. A. Carucci, K. Washenik, A. Weinstein, J. Shupack, and D. E. Cohen The Leukotriene Antagonist Zafirlukast as a Therapeutic Agent for Atopic Dermatitis Arch Dermatol, July 1, 1998; 134(7): 785 - 786. [Full Text] [PDF]

				T. F. Reiss, P. Chervinsky, R. J. Dockhorn, S. Shingo, B. Seidenberg, T. B. Edwards, and for the Montelukast Clinical Research Study Group Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic Asthma: A Multicenter, Randomized, Double-blind Trial Arch Intern Med, June 8, 1998; 158(11): 1213 - 1220. [Abstract] [Full Text] [PDF]

				B. Knorr, J. Matz, J. A. Bernstein, H. Nguyen, B. C. Seidenberg, T. F. Reiss, A. Becker, and for the Pediatric Montelukast Study Group Montelukast for Chronic Asthma in 6- to 14-Year-Old Children: A Randomized, Double-blind Trial JAMA, April 15, 1998; 279(15): 1181 - 1186. [Abstract] [Full Text] [PDF]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				M. E. Wechsler, E. Garpestad, S. R. Flier, O. Kocher, D. A. Weiland, A. J. Polito, M. M. Klinek, T. D. Bigby, G. A. Wong, R. A. Helmers, et al. Pulmonary Infiltrates, Eosinophilia, and Cardiomyopathy Following Corticosteroid Withdrawal in Patients With Asthma Receiving Zafirlukast JAMA, February 11, 1998; 279(6): 455 - 457. [Abstract] [Full Text] [PDF]

				B. C. Carlstedt Pharmacotherapy of Asthma Journal of Pharmacy Practice, June 1, 1997; 10(3): 147 - 164. [Abstract] [PDF]

				J. DRAZEN Clinical Pharmacology of Leukotriene Receptor Antagonists and 5-Lipoxygenase Inhibitors Am. J. Respir. Crit. Care Med., June 1, 1997; 157(6): 233S - 237. [Abstract] [Full Text]

				W. J. CALHOUN Summary of Clinical Trials with Zafirlukast Am. J. Respir. Crit. Care Med., June 1, 1997; 157(6): 238S - 246. [Abstract] [Full Text]

				R. J. HORWITZ, K. A. MCGILL, and W. W. BUSSE The Role of Leukotriene Modifiers in the Treatment of Asthma Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1363 - 1371. [Full Text]

				R. L. Bell, R. R. Harris, P. E. Malo, J. B. Bouska, T. K. Shaughnessy, K. I. Hulkower, C. D. W. Brooks, and G. W. Carter ABT-761 Attenuates Bronchoconstriction and Pulmonary Inflammation in Rodents J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1366 - 1373. [Abstract] [Full Text]

				M. Weinberger and L. Hendeles Theophylline in Asthma N. Engl. J. Med., May 23, 1996; 334(21): 1380 - 1388. [Full Text] [PDF]